LANXESS completes acquisition of Brazilian biocide manufacturer IPEL

Cologne

Specialty chemicals company LANXESS today, February 3, 2020, completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The competent anti-trust authorities approved the transaction beginning of January.

IPEL with headquarters in Jarinu, São Paulo, is one of Brazil’s leading biocide manufacturers and generated sales in the lower double-digit million euro range in 2018. With the acquisition, LANXESS is strengthening its position as one of the world’s leading manufacturers of antimicrobial active ingredients and formulations. In addition to around 100 employees and the production facility, LANXESS has taken over the Brazilian company’s laboratory facilities.

IPEL generates the majority of its sales with biocides and specialty chemicals for the paint and coating industry. The product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.

MORE ABOUT THIS TOPIC

INVESTOR NEWS

LANXESS suspends share buy-back

April 06, 2020
INVESTOR NEWS

LANXESS postpones Annual Stockholders' Meeting 2020 due to corona pandemic

March 23, 2020
INVESTOR NEWS

LANXESS achieves full-year target for 2019 despite challenging environment

March 11, 2020
INVESTOR NEWS

LANXESS decides to buy back shares

March 10, 2020
INVESTOR NEWS

LANXESS completes acquisition of Brazilian biocide manufacturer IPEL

February 03, 2020
X
Usage of Cookies
We would like to use cookies to better understand you use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our Privacy Statement.

OK Other Settings